Totals
- Total revenue
- $23,911,041
- Total expenses
- $24,221,152
- Contributions and grants received
- $19,139,955
- Grants paid
- $1,572,423
- Program service revenue
- $4,767,966
- Investment income
- $120
- Other revenue
- $3,000
- Total assets, end of year
- $11,242,073
- Total liabilities, end of year
- $7,577,144
- Net assets or fund balances, end of year
- $3,664,929
- Program services expenses (Part IX)
- $22,571,199
- Management and general expenses
- $1,574,846
- Fundraising expenses
- $75,107
- Program service expenses (Part III)
- $22,571,199
Program services were 93.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$0
-
1b · Membership dues
$0
-
1c · Fundraising events
$0
-
1d · Related organizations
$0
-
1e · Government grants (contributions)
$16,969,973
-
1f · All other contributions, gifts and grants
$2,169,982
-
1g · Noncash contributions included above
$511,255
-
2a · Program service revenue: Scientific Collaborations
total $4,767,966 · related or exempt $4,767,966 · unrelated business $0 · excluded $0
-
2f · All other program service revenue
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
3 · Investment income
total $120 · related or exempt $120 · unrelated business $0 · excluded $0
-
4 · Income from investment of tax-exempt bond proceeds
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
5 · Royalties
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
6c · Rental income or loss
real property $0 · personal property $0
-
7c · Gain or loss
securities $0 · other assets $0
-
8a · Fundraising events: contributions included on line 1c
$0
-
11d · All other revenue
total $3,000 · related or exempt $0 · unrelated business $3,000 · excluded $0
-
11e · Other revenue, total
$3,000
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $1,193,878 · program services $1,193,878
-
2 · Grants to domestic individuals
total $0 · program services $0
-
3 · Grants to foreign organizations and individuals
total $378,545 · program services $378,545
-
4 · Benefits paid to or for members
total $0 · program services $0
-
5 · Compensation of officers, directors and key employees
total $1,557,487 · program services $1,228,475 · management and general $322,871 · fundraising $6,141
-
6 · Compensation of disqualified persons
total $0 · program services $0 · management and general $0 · fundraising $0
-
7 · Other salaries and wages
total $11,614,969 · program services $10,752,867 · management and general $814,622 · fundraising $47,480
-
8 · Pension plan contributions
total $766,237 · program services $711,359 · management and general $52,654 · fundraising $2,224
-
9 · Other employee benefits
total $2,004,819 · program services $1,902,605 · management and general $96,287 · fundraising $5,927
-
10 · Payroll taxes
total $853,178 · program services $787,788 · management and general $62,816 · fundraising $2,574
-
11a · Fees: management
total $199,022 · program services $182,238 · management and general $16,020 · fundraising $764
-
11b · Fees: legal
total $614,838 · program services $571,723 · management and general $41,152 · fundraising $1,963
-
11c · Fees: accounting
total $248,432 · program services $227,481 · management and general $19,997 · fundraising $954
-
11d · Fees: lobbying
total $0 · program services $0 · management and general $0 · fundraising $0
-
11e · Fees: professional fundraising services
total $0 · fundraising $0
-
11f · Fees: investment management
total $0 · program services $0 · management and general $0 · fundraising $0
-
11g · Fees: other
total $2,217,335 · program services $2,208,189 · management and general $8,730 · fundraising $416
-
12 · Advertising and promotion
total $66,304 · program services $60,712 · management and general $5,337 · fundraising $255
-
13 · Office expenses
total $56,441 · program services $52,526 · management and general $3,737 · fundraising $178
-
14 · Information technology
total $633,519 · program services $604,166 · management and general $28,017 · fundraising $1,336
-
15 · Royalties
total $0 · program services $0 · management and general $0 · fundraising $0
-
16 · Occupancy
total $1,006,544 · program services $921,661 · management and general $81,019 · fundraising $3,864
-
17 · Travel
total $308,166 · program services $299,598 · management and general $8,178 · fundraising $390
-
18 · Travel or entertainment for public officials
total $0 · program services $0 · management and general $0 · fundraising $0
-
19 · Conferences, conventions and meetings
total $4,004 · program services $4,004 · management and general $0 · fundraising $0
-
20 · Interest
total $132 · program services $120 · management and general $11 · fundraising $1
-
21 · Payments to affiliates
total $0 · program services $0 · management and general $0 · fundraising $0
-
22 · Depreciation, depletion and amortization
total $16,582 · program services $15,183 · management and general $1,335 · fundraising $64
-
23 · Insurance
total $80,485 · program services $73,698 · management and general $6,478 · fundraising $309
-
24e · All other expenses
total $400,235 · program services $394,383 · management and general $5,585 · fundraising $267
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $0 · end of year $0
-
2 · Savings and temporary cash investments
beginning of year $3,014,650 · end of year $1,418,950
-
3 · Pledges and grants receivable
beginning of year $0
-
4 · Accounts receivable
beginning of year $4,020,715 · end of year $4,269,310
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $215,782 · end of year $249,287
-
10a · Land, buildings and equipment: cost or other basis
$5,404,522
-
10b · Land, buildings and equipment: accumulated depreciation
$99,996
-
10c · Land, buildings and equipment, net
beginning of year $68,693 · end of year $5,304,526
-
11 · Investments: publicly traded securities
beginning of year $0 · end of year $0
-
12 · Investments: other securities
beginning of year $0 · end of year $0
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $0 · end of year $0
-
15 · Other assets
beginning of year $0 · end of year $0
-
17 · Accounts payable and accrued expenses
beginning of year $1,762,734 · end of year $1,149,973
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $1,384,007 · end of year $897,810
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $10,150 · end of year $0
-
25 · Other liabilities
beginning of year $187,909 · end of year $5,529,361
-
27 · Net assets without donor restrictions
beginning of year $3,975,040 · end of year $3,645,836
-
28 · Net assets with donor restrictions
beginning of year $0 · end of year $19,093
Mission and programs · 2022
Mission
Sage Bionetworks is a nonprofit research organization founded in 2009 to accelerate the translation of data-intensive science into medicine. Drawing on our roots in open science, we develop and apply community practices that address barriers that limit the implementation and interpretation of computational biomedical research. We are modernizing how biomedical data and insights are collected, managed, and used, and we partner with scientists in academia, industry and the nonprofit sectors to ensure that data-intensive science programs lead to actionable results.
Activities or mission (Part I)
Sage Bionetworks is a strategic research organization with a mission to coordinate and link academic and commercial biomedical researchers, patients and citizens through a Commons that represents a new paradigm for genomics intellectual property, researcher cooperation and contributor evolved resources. This mission has several interdependent themes, including: conducting research on network models of disease; building the computational platform for the Commons; and activating public engagement.
-
Research Communities and Challenges: Sage Bionetworks conducts research independently as well as with collaborators worldwide across a variety of disease areas. We work to redefine how complex biological data is gathered, shared and used through open systems, incentives, and norms. Our work includes the building of platforms and services and undertaking research developing predictors relating to health. Research: As biological research has become more data intensive, the breadth of data and expertise required to address research problems has expanded. It requires the integrated efforts of a distributed set of researchers (such as bench/data scientists, data engineers, project managers, administrators, governance experts, and clinical researchers) with shared interests and complementary resources. Effective collaboration depends on a collective ability to work together in trusted ways that lead to translatable biomedical insights. We call this scientific coordination. Sage's scientific coordination stack includes: 1) hypothesis and data generation, 2) data curation, 3) analysis, 4) interpretation, and 5) dissemination. We focus on building a federated network of individuals who bring diverse expertise and approaches to develop robust solutions. Research projects include AMP AD and supplements for Ingestion, Longevity, Multi Scale, Diversity Cohorts May, TREAT AD, Model AD, M2OVE Consortium, RISK Variants, Depression Emory, BUADC, Helmsley VEIOBD, Boston Children's Hospital VEIOBD, MC2, CHOP INCLUDE, RECOVER, imCore, CTF Synodos, JHU NTAP, GFF NF, Gray Foundation, Gates COVID Cohort, HTAN, HTAN Supplement, iAtlas 3 & 4, AACR Genie, CD2H, CD2H COVID Supplement, Rochester Udall, Mayo Subtyping, RWJF Pioneering Ideas, FHCRC Accelerator in addition to other projects. Challenges: With algorithms playing an increasing role in biomedical analysis and patient care, there's a need for a more rigorous framework for evaluating and improving the capabilities of these algorithms. Sage Bionetworks has pioneered the development of concepts and infrastructure to objectively evaluate algorithms across a broad spectrum of biomedical domains, including bioinformatics, biomedical informatics, and clinical trials. As a trusted partner in hosting challenges and benchmarking initiatives, Sage serves as a broker between data generators and data modelers. We combine technology with biomedical and data science expertise to facilitate the objective assessment of algorithms on critical data sets, including proprietary data and algorithms that cannot be broadly shared. Sage works with the DREAM community to host open challenges. DREAM is recognized as a leader in biomedical competitions, successfully motivating research teams to address fundamental questions about systems biology and translational medicine and to advance computational methods. DREAM challenges invite participants to propose solutions - fostering collaboration and building communities in the process. Sage Bionetworks provides institutional support, along with the infrastructure to host challenges via our Synapse platform. Active Challenges hosted on the Synapse platform in 2022 included: RADx Long Covid, RARE-X, MOD, Bridge 2AI, BARDA, ITCR NIH, Anit-PDI Response Prediction DREAM, and Electronic Medical Record NLP DREAM.
Expenses $17,488,562 · Grants $14,760,515 · Revenue $18,000,189
-
Digital Health: Smartphones and other wearable sensors have put touchscreens and high-fidelity sensors into the pockets of billions of people. These technologies provide an opportunity to paint a rich understanding of health and disease in the everyday world outside of the clinic. They also provide communication tools that allow participants a more active voice in research programs. With our Digital Health program, we work to advance health research through practices that support the design, development and implementation of studies that use technology to monitor health outside of the clinical setting, and the analysis and sharing of the resulting study data. We help to derive and test digital biomarkers. We evaluate analytical methodologies to benchmark best practices in study design and data analysis. Sage's Digital Health program is built around Bridge, a technology platform for conducting biomedical research studies primarily using the ResearchKit (iOS) and ResearchStack (Android) frameworks. Bridge is composed of HIPAA-compliant web services and multi-language SDKs that facilitate: registration and informed consent to participate in research; web-based tools to design and schedule study surveys and sensor-based tasks; acquisition and secure transfer of multiple data types (surveys, sensors, audio, video, or custom data types); a study management portal with daily dashboard updates; and de-identification and storage of study data in our collaborative data science environment, Synapse. Digital Health studies active in 2022 included: Scripps AoU, NWU Toolbox, Biomarin PKU, DIAN, Pscorcast, MGH At Home, Columbia CZI COVID Registry, Wellcome Trust Databank, ADDF Digital Accelerators, M2C2, Cleveland Clinic Informed Consent, RECOVER Mobile Health Platform/Movile Health Repositories Working Group, 1KD Program funded by Wellcome LEAP Inc, and VA Merit.
Expenses $5,082,637 · Grants $4,390,099 · Revenue $5,481,111
As filed on the 2022 return.
Listed in Part VII
-
Mike Kellen
Chief Technology Officer
- Total calculated
- $306,209
- From this org
- $277,785
- From related orgs
- $0
- Other
- $28,424
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $277,785
- Bonus
- $0
- Other
- $1,056
- Deferred
- $0
- Nontaxable benefits
- $27,368
- Filer's total
- $306,209
-
Brian O'Connor
Chief Data Officer
- Total calculated
- $298,409
- From this org
- $272,938
- From related orgs
- $0
- Other
- $25,471
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $222,938
- Bonus
- $50,000
- Other
- $849
- Deferred
- $0
- Nontaxable benefits
- $24,623
- Filer's total
- $298,410
-
Kim Baggett
COO, Interim President
- Total calculated
- $246,429
- From this org
- $219,103
- From related orgs
- $0
- Other
- $27,326
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $169,103
- Bonus
- $50,000
- Other
- $1,433
- Deferred
- $0
- Nontaxable benefits
- $25,893
- Filer's total
- $246,429
-
Larsson Omberg
Vice President, Systems Biology
- Total calculated
- $232,703
- From this org
- $198,315
- From related orgs
- $0
- Other
- $34,388
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $198,315
- Bonus
- $0
- Other
- $768
- Deferred
- $0
- Nontaxable benefits
- $33,620
- Filer's total
- $232,703
-
Bruce Hoff
Director, Synapse Team
- Total calculated
- $227,485
- From this org
- $188,942
- From related orgs
- $0
- Other
- $38,543
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $188,942
- Bonus
- $0
- Other
- $1,332
- Deferred
- $0
- Nontaxable benefits
- $37,212
- Filer's total
- $227,486
-
Ljubomir Bradic
Director, Design
- Total calculated
- $226,373
- From this org
- $185,555
- From related orgs
- $0
- Other
- $40,818
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $185,555
- Bonus
- $0
- Other
- $1,208
- Deferred
- $0
- Nontaxable benefits
- $39,610
- Filer's total
- $226,373
-
Julie Bletz
Director, SCCE
- Total calculated
- $220,102
- From this org
- $185,581
- From related orgs
- $0
- Other
- $34,521
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $167,581
- Bonus
- $18,000
- Other
- $1,249
- Deferred
- $0
- Nontaxable benefits
- $33,271
- Filer's total
- $220,101
-
Erin Mounts
Director, Bridge Platforms
- Total calculated
- $216,491
- From this org
- $188,114
- From related orgs
- $0
- Other
- $28,377
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $188,114
- Bonus
- $0
- Other
- $1,316
- Deferred
- $0
- Nontaxable benefits
- $27,061
- Filer's total
- $216,491
-
Anna Greewood
Director, ADTR
- Total calculated
- $211,209
- From this org
- $184,548
- From related orgs
- $0
- Other
- $26,661
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $166,548
- Bonus
- $18,000
- Other
- $647
- Deferred
- $0
- Nontaxable benefits
- $26,014
- Filer's total
- $211,209
-
Christine Fabre Suver
Vice President, Governance
- Total calculated
- $207,463
- From this org
- $178,989
- From related orgs
- $0
- Other
- $28,474
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $178,989
- Bonus
- $0
- Other
- $707
- Deferred
- $0
- Nontaxable benefits
- $27,767
- Filer's total
- $207,463
-
Lara Mangravite
President
- Total calculated
- $147,687
- From this org
- $128,450
- From related orgs
- $0
- Other
- $19,237
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $128,450
- Bonus
- $0
- Other
- $500
- Deferred
- $0
- Nontaxable benefits
- $18,737
- Filer's total
- $147,687
-
Diane Gary
Secretary
- Total calculated
- $39,491
- From this org
- $33,686
- From related orgs
- $0
- Other
- $5,805
- Hours/week
- 50
Schedule J breakdown matched by us
- Base
- $33,686
- Bonus
- $0
- Other
- $282
- Deferred
- $0
- Nontaxable benefits
- $5,523
- Filer's total
- $39,491
-
Kathy Hudson
Director
- Total calculated
- $30,000
- From this org
- $30,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 1
-
Stephen Friend
Chairman of the Board
- Total calculated
- $0
- Hours/week
- 1
-
Eric Schadt
Director
- Total calculated
- $0
- Hours/week
- 1
-
Tony Ford-Hutchinson
Director
- Total calculated
- $0
- Hours/week
- 1
-
Gustavo Stolovitsky
Director
- Total calculated
- $0
- Hours/week
- 1
-
Cecilia Arradaza
Director
- Total calculated
- $0
- Hours/week
- 1
-
Tetsu Maruyama
Director
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Schedule J, Part I, Line 3
- Executive compensation was set by the Board of Directors Compensation Committee.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$289,400
CRI Immune Atlas: Platform for immune-oncology research and data sharing phase 2 and 3. Exceptional Longevity Data Management and Coordinating Center, design and perform cross-project analysis focused on harnessing systems biology-based techniques, such as multi-omic data integration, network analysis, machine learning, and statistical modeling, to investigate both aging and disease, as well as the interplay between them.
-
CRI Immune Atlas: Platform for immune-oncology research and data sharing phase 2 and 3. Defining regression models and validation methods for use in implementing statistical learning models for biomarker development in iAtlas. Add comprehensive tumor antigen prediction from multiple genomic sources to iAtlas datasets. Harmonize and curate data from additional IO clinical trials with genomic data for analysis using the IO response module.
-
University of Washington
$152,021
Partner to prototype and test best ways to build a Global Mental Health Databank that holds rich longitudinal data at scale from different global locations on approaches, treatments and interventions potentially relevant to anxiety or depression in 14-24 year olds.
-
University of California Los Angeles
$114,295
Lead evaluation and testing of new Synapse features and their incorporation into multiple challenges, including a lead study of prostate cancer Active Surveillance. Provide strategic advice, feature-testing and development, usage-scenarios and intensive testing.
-
Perform all work related to the proposed BRCA Pre-Cancer Atlas instance of the cBioPortal for Cancer Genomics. Build, maintain and run automated pipelines that transfer data from Synapse into BRCA Pre-Cancer Atlas Data Portal. Maintain all user logins and develop new Data Portal and cBioPortal features as they become relevant for the project. Provide user support, documentation, and outreach for the entire BRCA Pre Cancer Atlas.
-
$62,628
Phase 1 and 2: RECOVER Mobile Health Platform/Mobile Health Repositories Working Group: Develop process for MHP to collect PASC related mobile health data from participants and share this data with MHDR to clean curate, conduct QA/QC, store and provide access to researchers. Customization of the mobile health platform, implementation of mobile data collection among the various studies, as well as, the storing, curation, linkage, and analyses of the mobile health data.
-
Seven Bridges Genomics Inc
$55,257
Exceptional Longevity Data Management and Coordinating Center, develop integration between Sage's data sharing portal, Synapse, and CABATICA.
-
Multi-Consortia Coordinating Center (MC2 Center) for Cancer Biology: Building Interdisciplinary Scientific Communities, Coordinating Impactful Resource Sharing, and Advancing Cancer Research.
-
Exceptional Longevity Data Management and Coordinating Center, develop analytical methods for accommodating and exploring heterogeneity in large aggregated databases. They will also apply these methods with the other invetigators as well as researchers associated with the consortia that generated the aggregated data.
-
The Pennsylvania State University
$42,315
Phase 1 and 2: RECOVER Mobile Health Platform/Mobile Health Repositories Working Group: Develop process for MHP to collect PASC related mobile health data from participants and share this data with MHDR to clean curate, conduct QA/QC, store and provide access to researchers. Customization of the mobile health platform, implementation of mobile data collection among the various studies, as well as, the storing, curation, linkage, and analyses of the mobile health data.
The 10 largest by cash amount. The API serves every itemized grant.
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $378,545
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| Europe (including Iceland and Greenland) | 0 | 0 | Grantmaking | Wellcome is engaging Sage Bionetworks as a learning partner to prototype and test best ways to build a Global Metal Health Databank that holds rich longitudinal data at scale from different global locations on approaches, treatments and interventions potentially relevant to anxiety or depression in 14-24 year olds in order to help answer the question: "what works for whom and why in relation to prevention, treatment, stopping relapse or managing ongoing difficulties for anxiety or depression including at least some 14-24 year olds". | $230,799 |
| South Asia | 0 | 0 | Grantmaking | Wellcome is engaging Sage Bionetworks as a learning partner to prototype and test best ways to build a Global Metal Health Databank that holds rich longitudinal data at scale from different global locations on approaches, treatments and interventions potentially relevant to anxiety or depression in 14-24 year olds in order to help answer the question: "what works for whom and why in relation to prevention, treatment, stopping relapse or managing ongoing difficulties for anxiety or depression including at least some 14-24 year olds". | $61,374 |
| Sub-Saharan Africa | 0 | 0 | Grantmaking | Wellcome is engaging Sage Bionetworks as a learning partner to prototype and test best ways to build a Global Metal Health Databank that holds rich longitudinal data at scale from different global locations on approaches, treatments and interventions potentially relevant to anxiety or depression in 14-24 year olds in order to help answer the question: "what works for whom and why in relation to prevention, treatment, stopping relapse or managing ongoing difficulties for anxiety or depression including at least some 14-24 year olds". | $86,372 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| Europe (including Iceland and Greenland) | $230,799 | Wire | $0 | — | — |
| South Asia | $61,374 | Wire | $0 | — | — |
| Sub-Saharan Africa | $86,372 | Wire | $0 | — | — |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 0
- Other grantees (Part II line 3)
- 5
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 14 November 2023
- IRS schema version
- 2022v5.0
- Source object
- 202313189349304141
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.